About Kidron Capital
Kidron Capital is a company. It operates as a HealthTech. Kidron Capital offers products and services including Chemotherapy Vascular Port, PCOS Ovulation Technology, AKI Prevention Technology, Longevity Skin Rejuvenation, and Maternal Health Retractor.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kidron Capital
Kidron Capital offers a comprehensive portfolio of products and services, including Chemotherapy Vascular Port, PCOS Ovulation Technology, AKI Prevention Technology, Longevity Skin Rejuvenation, and Maternal Health Retractor.
Innovative vascular port designed for female chemotherapy patients.
Breakthrough technology developed to restore ovulation in PCOS.
Technology created to prevent AKI in cardiac surgery.
Skin rejuvenation solution based on mitochondrial dysfunction insights.
Surgical retractor designed for C-sections in maternal health.
Funding Insights of Kidron Capital
Detailed funding history for Kidron Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kidron Capital
Investment portfolio details for Kidron Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kidron Capital
Detailed financials for Kidron Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kidron Capital Comparisons
Peer comparison for Kidron Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kidron Capital
Detailed competitors of Kidron Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kidron Capital
Complete news archive for Kidron Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kidron Capital
Kidron Capital is engaged in identifying and investing in untapped opportunities within womens health. The company targets a range of indications and modalities, including medical devices, diagnostics, therapeutics, digital health, and consumer solutions. Investments are made across key geographies such as the USA, Europe, and Israel. Emphasis is placed on technologies addressing unmet medical needs in female patients, spanning female-specific diseases and general conditions disproportionately affecting women. Solutions are grounded in scientific evidence, meet regulatory standards, and are often protected by patents.
Kidron Capital offers Chemotherapy Vascular Port, PCOS Ovulation Technology, AKI Prevention Technology, Longevity Skin Rejuvenation, and Maternal Health Retractor.